Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From the updates:
From the updates:
Nope. I was commenting on the link given by blabla which explicitly said they were trying to raise the money so he could start the treatment. Why don't you go back and read the link provided?
Control arms have patient level data. At least valid ones in the eyes of the FDA.
We know you are an idiot.
He is not “being treated with DCVax-L” but I know your reading comprehension is lacking.
More bread crumbs. Way to go flipper. Remember all the links to big pharma back in 2016 or 2017 when NWBO announced a tiny combo trial with free Keytruda and everyone said it was a partnership/buyout?
Same shit different year.
Merck has nothing and wants nothing to do with NWBO. They have 10x the oncologists on staff as the ones that have already panned the data and trial. Do you think they didn’t do the same IF they even bothers looking at the company?
Delusional idiots on a message board don’t change that.
They should PR that the majority of the money they have pilfered from the public has gone to build out Cognate and Advent for LP to sell for her personal gain.
Your answer to providing patient level data is to show campus layout of a legit company? Wow you are an idiot.
Median age being equal is irrelevant. They need patient level data for the control arm to compare apples to apples. They don't have it which is why the ECA is bullshit and why the FDA requires patient level data.
Ever notice the 3 people who NWBO always parades around as success stories were in their 40s when diagnosed?
Age groups have only been broken down as <>65. The way the DCVax trial screened out so many patients, I'll bet the 40-50 year old age group was greatly represented in the DCVax trial.
Why didn't they release the patient level data? Hmmm.
It's 3+ years after data lock. They don't want to submit anything because then the gig is up.
Dr Bot, regurgitating the same tired attack day after day after day.
What a shill.
Show me the patient breakdown and the control arm they are comparing to. The FDA has made it perfectly clear that the ECA needs patient level data and needs to be defined prior to running the whole trial.
A tweet from an idiot is not data.
I'll wait.
Call it The Grand Delusion.
Yes, everyone is afraid that the company will submit an application to a tiny market like the UK that will get rejected 2 1/2 years after it SHOULD have been submitted, and months after the company SAID it would have been submitted.
"Trying to move up" on <400K volume because there's no interest in buying at the ask.
Just make up a lie and pretend DI told you.
What's two billion OS, anyway! It's coming. Or she'll rename the company, change the ticker, and sneak an R/S in and nobody but this board will notice. Then she can repeat it all over again.
He's talking about DCVax orphan drug status which it has had since 2002 (making it irrelevant considering they haven't applied for crap in the US and it's almost 2024).
It doesn't have Fast Track designation. Other dendritic cell vaccines for GBM do, like DOC1021. It's early stage though and doesn't work either.
Did they PR how awesome their publisher was?
Nice cherrypicked data like every other shill. I remember when all the shills were saying "I didn't sell so I haven't lost anything". Same goes for now. You haven't made a penny either unless you sold. How much have you sold?
Of course you've been around since 2015 and didn't buy any when this was above $5. Why not expand your prices to when you were hyping the cheapies in 2015-16?
It was 2.15 when you added more Jan 11, 2016
Or this gem
Yes one of the many slimy ass things this company has done to pump up the stock price so their cronies can dump it. Where do you think the billion shares has come from? Day to day business expenses? For the $100 million the company stole from Woodford, they'd be able to get their fictitious publisher to actually get crap right and submit something without having to dilute the hell out of shareholders, don't you think?
Your "facts" had nothing to do with what I said. Zero ORR is a fact for Direct. Did you even read the Direct resluts? It's not foul language to call a moron a moron. Liau is a great surgeon whose treatment doesn't work as a standalone therapy. She proved that with the P3. She is among the many doctors who tried to develop a treatment that didn't work. Most treatments don't or we'd already have cures for most cancers. Why do you think they are doing combo trials now and not curing all these people with L? Because it doesn't work and is expensive and invasive.
$150K in the DC area is barely a living wage. Poor for a doctor, actually. I work there. He probably commuted an hour to DC on $150K.
He can't read.
For what, you idiot?
Keep up with the conversation you moron. When I mentioned ORR and one of your little clone buddies told you to type a stupid comment, I was talking about Direct, which is as worthless as L. The tumors did nothing. That's zero ORR.
No little charts you are being fed are doing anything to change that.
We are talking about Direct you idiot, which had zero ORR. It was a safety study with the primary endpoint of number of patients with AEs. I could have saved them money and told them their placebo was safe.
The secondary endpoint was number of patients with tumor response and no patients had any objective response rate which is how a response is measured.
Again you don't understand basic stuff the dumbest of morons would understand, and you certainly don't understand anything about this company or it's sham products.
There was no JAMA article on Direct because they shelved it because it didn't do anything.
DCVax gets an immune response like grapefruit juice gets an immune response.
Says the shill who disappeared after he couldn't get every post deleted so he could renegotiate his payment scale to $0.01 for every time he says "fudster" like an idiot.
Let's discuss publishers like this is a damn children's book or something! I'll bet nobody can find another PR of a biotech discussing a publisher in a PR like this is 1960 or something, let alone blaming multiple "publishers" for submission woes.
Why don't you discuss this piece of crap stock? You know, the one with shitty data that every oncologist who wasn't involved in the crappy JAMA article routinely slams? The one that data locked 3+ years ago and still can't submit anything and makes childish BS excuses as to why? The one who paid for not one but two CDMOs for LP to sell for profit to herself? The one that lied about Swiss approval, having plenty of money to advance Direct (from a failed trial with 0 ORR to another failed trial with 0 ORR), and the 2015 IA. The one that blatantly ripped off it's only legit financier?
Or would you rather just trash renowned oncologists and other companies because there are no more breadcrumbs for this piece of crap?
Companies trying to cure cancer generally give data and info in tiny increments to the powers that be. Wouldn’t want to submit a whole package because it could get lost on the Pony Express, NWBO’s favorite form of data delivery.
Says the guy whose source has been a loaf of bread for 10 years.
She’s never been right about anything. Why start now.
Right here idiot.
Nah I sit in my nice house that I bought from good investments unlike this turd. 5 minutes from Cognate HQ. Remember the CDMO you paid for via buying shares that LP sold and kept all the money for herself?
Great, So a company that has taken 10 years to run a small P3 and still has submitted nothing is in charge of running a confirmatory trial to prove that they can automate making their placebo that does nothing with their million dollar nothing maker that Corning couldn't find a use for.
All in house! Yay!
Easy to manipulate with a pump stating they are submitting something so their friends can dump shares.